• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Health News > June 16, 2010

      New Drug to Cut Flab of Diabetics

      Posted AtExpressindia.com

      New Delhi Obese diabetics will soon have a better option to reduce their weight and consequently their blood sugar levels, with a new drug, Victoza (liraglutide), all set to be launched in India this month.

      Already launched in Europe and the US, the drug will hit the stores in India — one of the countries with the highest disease burden and which has over 650 brands of anti-diabetic drugs already available — on June 6. Victoza by Novo Nordisk, according to doctors, will be another option to injectable Byetta, introduced in 2008, and other oral weight-reducing Diabetes drugs.

      While Victoza will also be injectable, it is an improvement over the other anti-diabetes drugs used to reduce weight like Januvia and Metformin, say doctors. Their opinion is based on a recent study published in the Lancet, which compared Victoza with Januvia.

      The study suggested that Victoza “produced greater reductions” than Januvia. The study was a 26-week randomised trial, comparing safety and efficacy of two recommended doses of Victoza (1.2 and 1.8 mg) with one daily dose of Januvia (100 mg), all added to Metformin.

      The study was conducted in Europe and North America on 665 people with type II diabetes.

      Says Dr Anoop Misra, Director and Head (Department of Diabetes and Metabolic Diseases), Fortis hospitals: “It will be a good drug for obese diabetics — one step ahead of other weight-reducing Metformin, which reduces 1-2 kgs of weight, and Byetta, which reduces about 3-4 kgs of weight.”

      Dr Misra says Victoza, however, cannot be compared with insulin as Victoza doesn’t produce “very low blood sugar levels”. “Though the drug has been evaluated for three years, in real-life situation we do not have more details. While the experiment on animals has reported thyroid tumours, in humans no such problem is reported but one needs to be cautious. Nausea may also be a side effect in 20 per cent of the people,” he adds.

      In April 2009, a US Food and Drug Administration (FDA) advisory committee expressed its concern that the drug may cause thyroid tumours in mice and rats. In January 2010, however, the FDA approved Victoza for the treatment of type II diabetes in adults.

      The drug has been approved as an auxiliary treatment to diet and exercise to enhance glycaemic control in adults suffering from type II diabetes.

      June 16, 2010


      Share this Article!

    Back to top^